tirzepatide components Tirzepatide, a New Era of Dual-Targeted Treatment for Diabetes and Obesity: A Mini-Review CID 163285897 | C225H348N48O68 |

A study published last week reported on whether those who take semaglutide are more likely to report having suicidal thoughts.It continues a see-saw, tug-of-war over scientific evidence about the risks associated with these medications. Guest:Dr Norman Swan, host of What's That Rash

- Report any side effects or concerns to your doctor immediately

Doctors and groups representing employers said theyre increasingly hearing about companies cutting weight loss drugs out of health plans next year.

This article explains the benefits of not waiting to learn about your GLP-1 options.

Anyone considering using or just starting a GLP-1 medication

Four months later, I was down to 140 lbs a loss of nearly 130 lbs